Latest Articles

Publication Date
Incidental Primary Ovarian Squamous Cell Carcinoma Arising in Endometriosis Presenting As Adenomyosis-Related Abnormal Uterine Bleeding.

Adenomyosis often coexists with endometriosis, which primarily involves the ovary and can lead to endometriosis‑associated ovarian cancers, most commonly endometrioid and clear‑cell carcinomas. Ovarian squamous cell carcinoma (OSCC) arising in …

Published: Aug. 22, 2025, midnight
NIH award to explore socio-genomic factors of local endometrial cancer survival rates - EurekAlert!

NIH award to explore socio-genomic factors of local endometrial cancer survival rates EurekAlert!

Published: Aug. 21, 2025, 4:11 p.m.
Ozempic Linked to Reduced Cancer Risk - Newsweek

Ozempic Linked to Reduced Cancer Risk Newsweek

Published: Aug. 21, 2025, 3 p.m.
Wayne State researcher receives NIH award to explore socio-genomic factors of local endometrial cancer survival rates - Today@Wayne

Wayne State researcher receives NIH award to explore socio-genomic factors of local endometrial cancer survival rates Today@Wayne

Published: Aug. 21, 2025, 1:46 p.m.
NIH Award to Explore Socio-Genomic Factors of Local Endometrial Cancer Survival Rates | Newswise - Newswise

NIH Award to Explore Socio-Genomic Factors of Local Endometrial Cancer Survival Rates | Newswise Newswise

Published: Aug. 21, 2025, 1:40 p.m.
NR4A1 Acts as a Nutrient Sensor That Inhibits the Effects of Aging.

Orphan nuclear receptor 4A1 (NR4A1) is a member of the NR4A subfamily that was initially discovered as an intermediate early gene expressed in response to stressors, including inflammatory agents. This …

Published: Aug. 21, 2025, midnight
BioNTech’s Promising Phase III Study on Recurrent Endometrial Cancer - TipRanks

BioNTech’s Promising Phase III Study on Recurrent Endometrial Cancer TipRanks

Published: Aug. 20, 2025, 4:07 p.m.
AstraZeneca’s Phase III Study on Endometrial Cancer: A Potential Game Changer? - TipRanks

AstraZeneca’s Phase III Study on Endometrial Cancer: A Potential Game Changer? TipRanks

Published: Aug. 20, 2025, 4:07 p.m.
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers - TipRanks

Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers TipRanks

Published: Aug. 20, 2025, 4:06 p.m.
Ahmedabad doctor’s studies on novel techniques in treatment of endometrial cancer and bowel endometriosis published in international journals - APN News

Ahmedabad doctor’s studies on novel techniques in treatment of endometrial cancer and bowel endometriosis published in international journals APN News

Published: Aug. 20, 2025, 11:15 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!